KPIs & Operating Metrics(New)
Growth Metrics

Procter & Gamble (PG) EPS (Weighted Average and Diluted) (2016 - 2025)

Procter & Gamble (PG) has disclosed EPS (Weighted Average and Diluted) for 17 consecutive years, with $1.78 as the latest value for Q4 2025.

  • Quarterly EPS (Weighted Average and Diluted) fell 5.32% to $1.78 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.75 through Dec 2025, up 7.48% year-over-year, with the annual reading at $6.51 for FY2025, 8.14% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was $1.78 at Procter & Gamble, down from $1.95 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was $1.95 in Q3 2025, with the low at $1.13 in Q2 2021.
  • Average EPS (Weighted Average and Diluted) over 5 years is $1.52, with a median of $1.53 recorded in 2024.
  • Peak annual rise in EPS (Weighted Average and Diluted) hit 34.29% in 2024, while the deepest fall reached 12.02% in 2024.
  • Over 5 years, EPS (Weighted Average and Diluted) stood at $1.66 in 2021, then fell by 4.22% to $1.59 in 2022, then decreased by 11.95% to $1.4 in 2023, then skyrocketed by 34.29% to $1.88 in 2024, then decreased by 5.32% to $1.78 in 2025.
  • According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods came in at $1.78, $1.95, and $1.48 for Q4 2025, Q3 2025, and Q2 2025 respectively.